forecast

Pharma pullback from rare diseases threatens progress

Because pharma has pulled back from rare diseases, Zaks's colleagues in rare disease face challenges, and the economic incentives for innovation cannot be assumed to persist without careful policy and reimbursement design.

forecastpending

Speaker

Tal Zaks

Evidence Quote

“we need to be super careful and super mindful of the policy implications”

Source

Bridging Science, Medicine, and Returns— Invest Like the Best
Created: 11/19/2026, 4:01:33 PM

Your notes

Loading notes...